We are monitoring the impact of COVID-19 on Influenza Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1621
Share on
Share on

Global Influenza Market Analysis – By Product Type (Vaccines & Drugs), Consumer and Region - Size, Share, Trends, Growth Opportunities Assessment, Industry Forecast | 2019 - 2024

Pulished: February, 2020
ID: 1621
Pages: 170

Global Influenza Market Size & Growth (2019 - 2024)

The size of the Global Influenza Market is expected to reach USD 10.59 billion by 2024 from USD 7.03 billion in 2019, growing at a CAGR of 8.54% during the forecast period, 2019 - 2024.

Influenza is a flu or viral infection which affects the respiratory system. The person affected with influenza may suffer from usual symptoms such as headache, fever, fatigue, cough, muscle aches, congestion, and running nose. Basically, there are four types of influenza viruses which are type A, B, C, and D. These virus travels through the respiratory system and can transmit through direct contact or by in taking virus-infected air particles. Influenza can be ideally prevented by vaccination. 

The significant factors that are boosting the growth of the global influenza market are increased focus of governments to provide better medical solutions for the people, enhancement of existing vaccines, low risk of side effects associated with influenza vaccines. The other factors that are boosting the growth of the influenza market are increased funding for research and development activities, the emergence of novel vaccines, and increased prevalence of medical tourism.

The major factors that are challenging the growth of the global influenza market are the time required for the production of the vaccine, and the manufacturing costs associated with the development that is very high.  

The influenza market is expected to provide lucrative growth opportunities for the key players in the market, owing to the increased account of immunization programs at regular intervals. Availability of a variety of influenza vaccines that have been prequalified by the world health organization and bought by united nation agencies have provided a number of opportunities for the growth of the global influenza market and is expected to continue the trend during the forecast period. Also, many influenza vaccines for treating influenza A virus in animals are under development phase and trials which are supposed to be launched over time. Influenza vaccines are being modified specially for seasons to tackle the virus strains which alter with each season; these factors are pushing the significant market players to develop new vaccines on regular intervals to milk the opportunities of the global influenza market.  

Key happenings in this market in the recent past:

  • ResVax vaccine, a vaccine developed Novavax Company for RSV diseases which have completed phase 3 of the trial process and the outcomes have been announced at the IDSOG meeting in August 2019.
  • Emergent BioSolutions Company has developed a vaccine called NuThrax anthrax vaccine for which the company has enrolled patients to begin the phase 3 trial of clinical study in 2018. The vaccine is a combination of anthrax and BioThrax vaccine developed by the Emergent, which improves the immune response of the body.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 - 2024

Segments Covered

By Product Type, Consumer and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Sanofi-Pasteur (U.S.), AstraZeneca (United Kingdom), F. Hoffmann-La Roche (Switzerland), Novartis (Switzerland), GlaxoSmithKline (U.K.), Pfizer Inc. (U.S.), Merck & Co. (U.S.), Abbott Laboratories (U.S.), Mitsubishi Tanabe Pharma Corporation (Japan) and CSL Limited (Australia)

 

This research report on the Global Influenza Market segmented and sub-segmented into the following categories and analyzed market size and forecast for each segment until 2024.

Influenza Market - By Product Type:

  • Vaccines
  • Drugs

On the basis of product type, the Vaccines (Fluzone, Afluria, Fluvirin, Flublok, and others) segment commands major market share which is estimated to be more than 80% and is anticipated to be the fastest-growing segment during the forecast period.

Influenza Market - By Consumer:

  • Children
  • Adults

Regional Analysis:

North America is leading the global influenza vaccine market by contributing the largest share of revenues and is expected to continue the trend owing to the factors such as the increased focus of governments on immunization programs, improvements in vaccine administration, increased incidence of influenza in the region, and the influx of new vaccines. LAMEA is another major contributor to the global market and is expected to grow at a high pace during the forecast period due to the factors like an increase in disposable income, advancements of healthcare facilities, and escalated growth of economies.

Most promising companies leading the Global Influenza Market profiled in this report are:

  1. Sanofi-Pasteur (U.S.)
  2. AstraZeneca (United Kingdom)
  3. F. Hoffmann-La Roche (Switzerland)
  4. Novartis (Switzerland)
  5. GlaxoSmithKline (U.K.)
  6. Pfizer Inc. (U.S.)
  7. Merck & Co. (U.S.)
  8. Abbott Laboratories (U.S.)
  9. Mitsubishi Tanabe Pharma Corporation (Japan)
  10. CSL Limited (Australia)

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product Type                             

                                5.1.1 Introduction           

                                5.1.2 Vaccines   

                                5.1.3 Drugs         

                                5.1.4  Y-o-Y Growth Analysis, By Product              

                                5.1.5  Market Attractiveness Analysis, By Product            

                                5.1.6  Market Share Analysis, By Product              

                5.2 Type                              

                                5.2.1 Introduction           

                                5.2.2 Safety Biomarkers

                                5.2.3 Efficacy Biomarkers             

                                5.2.4 Validation Biomarkers        

                                5.2.5  Y-o-Y Growth Analysis, By Type    

                                5.2.6  Market Attractiveness Analysis, By Type  

                                5.2.7  Market Share Analysis, By Type    

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Diagnostics Development 

                                5.3.3 Drug Discovery and Development

                                5.3.4 Personalised Medicine      

                                5.3.5 Disease Risk Assessment  

                                5.3.6 Other Applications               

                                5.3.7  Y-o-Y Growth Analysis, By Application        

                                5.3.8  Market Attractiveness Analysis, By Application      

                                5.3.9  Market Share Analysis, By Application       

                5.4 Disease Indications                 

                                5.4.1 Introduction           

                                5.4.2 Cancer      

                                5.4.3 CardiovascularDisorders    

                                5.4.4 Neurological Disorders       

                                5.4.5 Immunological Disorders  

                                5.4.6 Other Diseases      

                                5.4.7  Y-o-Y Growth Analysis, By Disease Indications        

                                5.4.8  Market Attractiveness Analysis, By Disease Indications 

                                5.4.9  Market Share Analysis, By Disease Indications 

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By Type

                                                6.1.3.4 By Application

                                                6.1.3.5 By Indication

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By Type

                                                6.1.4.4 By Application

                                                6.1.4.5 By Indication

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By Type

                                                6.1.5.4 By Application

                                                6.1.5.5 By Indication

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Sanofi-Pasteur                          

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 AstraZeneca                               

                8.3 F. Hoffmann-La Roche                           

                8.4 Novartis                       

                8.5 GlaxoSmithKline                       

                8.6 Pfizer Inc.                    

                8.7 Merck & Co.                               

                8.8 Abbott Laboratories                               

                8.9 Mitsubishi Tanabe Pharma Corporation                         

                8.10 CSL Limited                               

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Influenza Market By Region, From 2019-2024 ( USD Billion )
  2. Global Influenza Market By Product Type, From 2019-2024 ( USD Billion )
  3. Global Vaccines Market By Region, From 2019-2024 ( USD Billion )
  4. Global Drugs Market By Region, From 2019-2024 ( USD Billion )
  5. Global Influenza Market By Consumer, From 2019-2024 ( USD Billion )
  6. Global Children Market By Region, From 2019-2024 ( USD Billion )
  7. Global Adults Market By Region, From 2019-2024 ( USD Billion )
  8. North America Influenza Market By Product Type, From 2019-2024 ( USD Billion )
  9. North America Vaccines Market By Region, From 2019-2024 ( USD Billion )
  10. North America Drugs Market By Region, From 2019-2024 ( USD Billion )
  11. North America Influenza Market By Consumer, From 2019-2024 ( USD Billion )
  12. North America Children Market By Region, From 2019-2024 ( USD Billion )
  13. North America Adults Market By Region, From 2019-2024 ( USD Billion )
  14. United States Influenza Market By Product Type, From 2019-2024 ( USD Billion )
  15. United States Influenza Market By Consumer, From 2019-2024 ( USD Billion )
  16. Canada Influenza Market By Product Type, From 2019-2024 ( USD Billion )
  17. Canada Influenza Market By Consumer, From 2019-2024 ( USD Billion )
  18. Europe Influenza Market By Product Type, From 2019-2024 ( USD Billion )
  19. Europe Vaccines Market By Region, From 2019-2024 ( USD Billion )
  20. Europe Drugs Market By Region, From 2019-2024 ( USD Billion )
  21. Europe Influenza Market By Consumer, From 2019-2024 ( USD Billion )
  22. Europe Children Market By Region, From 2019-2024 ( USD Billion )
  23. Europe Adults Market By Region, From 2019-2024 ( USD Billion )
  24. U.K. Influenza Market By Product Type, From 2019-2024 ( USD Billion )
  25. U.K. Influenza Market By Consumer, From 2019-2024 ( USD Billion )
  26. Germany Influenza Market By Product Type, From 2019-2024 ( USD Billion )
  27. Germany Influenza Market By Consumer, From 2019-2024 ( USD Billion )
  28. France Influenza Market By Product Type, From 2019-2024 ( USD Billion )
  29. France Influenza Market By Consumer, From 2019-2024 ( USD Billion )
  30. Italy Influenza Market By Product Type, From 2019-2024 ( USD Billion )
  31. Italy Influenza Market By Consumer, From 2019-2024 ( USD Billion )
  32. Spain Influenza Market By Product Type, From 2019-2024 ( USD Billion )
  33. Spain Influenza Market By Consumer, From 2019-2024 ( USD Billion )
  34. Asia-Pacific Influenza Market By Product Type, From 2019-2024 ( USD Billion )
  35. Asia-Pacific Vaccines Market By Region, From 2019-2024 ( USD Billion )
  36. Asia-Pacific Drugs Market By Region, From 2019-2024 ( USD Billion )
  37. Asia-Pacific Influenza Market By Consumer, From 2019-2024 ( USD Billion )
  38. Asia-Pacific Children Market By Region, From 2019-2024 ( USD Billion )
  39. Asia-Pacific Adults Market By Region, From 2019-2024 ( USD Billion )
  40. Japan Influenza Market By Product Type, From 2019-2024 ( USD Billion )
  41. Japan Influenza Market By Consumer, From 2019-2024 ( USD Billion )
  42. China Influenza Market By Product Type, From 2019-2024 ( USD Billion )
  43. China Influenza Market By Consumer, From 2019-2024 ( USD Billion )
  44. India Influenza Market By Product Type, From 2019-2024 ( USD Billion )
  45. India Influenza Market By Consumer, From 2019-2024 ( USD Billion )
  46. Australia Influenza Market By Product Type, From 2019-2024 ( USD Billion )
  47. Australia Influenza Market By Consumer, From 2019-2024 ( USD Billion )
  48. South Korea Influenza Market By Product Type, From 2019-2024 ( USD Billion )
  49. South Korea Influenza Market By Consumer, From 2019-2024 ( USD Billion )
  50. Latin America Influenza Market By Product Type, From 2019-2024 ( USD Billion )
  51. Latin America Vaccines Market By Region, From 2019-2024 ( USD Billion )
  52. Latin America Drugs Market By Region, From 2019-2024 ( USD Billion )
  53. Latin America Influenza Market By Consumer, From 2019-2024 ( USD Billion )
  54. Latin America Children Market By Region, From 2019-2024 ( USD Billion )
  55. Latin America Adults Market By Region, From 2019-2024 ( USD Billion )
  56. Brazil Influenza Market By Product Type, From 2019-2024 ( USD Billion )
  57. Brazil Influenza Market By Consumer, From 2019-2024 ( USD Billion )
  58. Argentina Influenza Market By Product Type, From 2019-2024 ( USD Billion )
  59. Argentina Influenza Market By Consumer, From 2019-2024 ( USD Billion )
  60. Mexico Influenza Market By Product Type, From 2019-2024 ( USD Billion )
  61. Mexico Influenza Market By Consumer, From 2019-2024 ( USD Billion )
  62. Rest of Latin America Influenza Market By Product Type, From 2019-2024 ( USD Billion )
  63. Rest of Latin America Influenza Market By Consumer, From 2019-2024 ( USD Billion )
  64. Middle East & Africa Influenza Market By Product Type, From 2019-2024 ( USD Billion )
  65. Middle East & Africa Vaccines Market By Region, From 2019-2024 ( USD Billion )
  66. Middle East & Africa Drugs Market By Region, From 2019-2024 ( USD Billion )
  67. Middle East & Africa Influenza Market By Consumer, From 2019-2024 ( USD Billion )
  68. Middle East & Africa Children Market By Region, From 2019-2024 ( USD Billion )
  69. Middle East & Africa Adults Market By Region, From 2019-2024 ( USD Billion )
  70. Middle East Influenza Market By Product Type, From 2019-2024 ( USD Billion )
  71. Middle East Influenza Market By Consumer, From 2019-2024 ( USD Billion )
  72. Africa Influenza Market By Product Type, From 2019-2024 ( USD Billion )
  73. Africa Influenza Market By Consumer, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample